|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme显示文摘 | SCHACKERT H K APPELT H | 2005 | J Cancer Res Clin Oncol2005，131，2： | 1 |
| 2 | Good or Bad,We Want it Now:Fixed - cost Present Bias for Gains and Losses Explains Magnitude Asymmetries in Intertemporal Choice 显示文摘 | HARDISTY D J APPELT K C WEBER E U | 2013 | Journal of Behavioral Decision Making2013，26，4： | 1 |
| 3 | Preventive versus treatment effect of AG3340,a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization显示文摘 | El-Bradey M Cheng L Bartsch DU Appelt K Rodanant N Bergeron-Lynn G | 2004 | J Ocul Pharmacol Ther2004，20，3： | 1 |
| 4 | The Decision Making Individual Differences Inventory and guidelines for the study of individual differences in judgment and decision-making research显示文摘 | APPELT K C MILCH K F HANDGRAAF M J J | 2011 | Judgment and Decision Making2011，6，3： | 1 |
| 5 | Thermal characterization of a bis- maleimide bis- cyanate epoxy thermosetting resin for composites显示文摘 | Gotro J T Appelt B K Papathomas KI | 1987 | Polym Comp1987，8，1： | 1 |
| 6 | Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival 显示文摘 | Stanojlovic S Schlickeiser S Appelt C Vogt K Schmitt-Knosalla I Haase S | 2010 | Graefes Arch Clin Exp Ophthalmol2010，248，10： | 1 |
| 7 | From individual preference construction to group decisions: Framing effects and group processes显示文摘 | Milch K F Weber E U Appelt K C | 2009 | Organizational Behavior and Human Decision Processes2009，108，2： | 1 |
| 8 | From individual preference construction to group decisions:framing effects and group processes显示文摘 | Milch K F Weber E U Appelt K C Handgraaf M J J Krantz D H | 2009 | Organizational Behavior and Human Decision Processes2009，，108： | 1 |
| 9 | The effect of prinomastat (AG3340), a synthetic inhibi- tor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy显示文摘 | Ozerdem U Mach-Hofacre B Keefe K Pham T Souls K Appelt K | 2001 | Ophthalmic Res2001，33，1： | 1 |
| 10 | Fine pitch copper wire bonding in high volume production显示文摘 | Appelt B K Tseng A Chen C H | 2011 | Microeleetronics Reliability2011，51，： | 1 |
| 11 | 肾损伤的临床诊治经验显示文摘肾损伤临床较少见,国际泌尿外科协会和欧洲泌尿外科协会曾制定泌尿系统损伤诊治指南,文献报道保守治疗同样合理,较手术疗法有更大意义。 | Appelt K( et al.) 李金华(摘译) 陈志强(校) | 2012 | 中华泌尿外科杂志2012，33，9： | 0 |
| 12 | Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment显示文摘Intermittent injections of parathyroid hormone(iPTH) are applied clinically to stimulate bone formation by osteoblasts, although continuous elevation of parathyroid hormone(PTH) primarily results in increased bone resorption. Here, we identified Calca,encoding the sepsis biomarker procalcitonin(ProCT), as a novel target gene of PTH in murine osteoblasts that inhibits osteoclast formation. During iPTH treatment, mice lacking ProCT develop increased bone resorption with excessive osteoclast formation in both the long bones and axial skeleton. Mechanistically, ProCT inhibits the expression of key mediators involved in the recruitment of macrophages, representing osteoclast precursors. Accordingly, ProCT arrests macrophage migration and causes inhibition of early but not late osteoclastogenesis. In conclusion, our results reveal a potential role of osteoblast-derived ProCT in the bone microenvironment that is required to limit bone resorption during iPTH. | Anke Baranowsky Denise Jahn Shan Jiang Timur Yorgan Peter Ludewig Jessika Appelt Kai K.Albrecht Ellen Otto Paul Knapstein Antonia Donat Jack Winneberger Lana Rosenthal Paul Köhli Cordula Erdmann Melanie Fuchs Karl-Heinz Frosch Serafeim Tsitsilonis Michael Amling Thorsten Schinke Johannes Keller | 2022 | Bone Research2022，10，1： | 0 |
| 13 | 肾损伤的临床诊治经验显示文摘国际泌尿外科协会和欧洲泌尿外科踟会曾制定泌尿系统损伤诊治指南,当前文献中保守疗法较手术疗法有更大意义,严重肾损伤采用非手术疗法者逐渐增多,保守治疗也同样合理。 | Appelt K 李金华(摘译) 陈志强(校) | 2011 | 中华泌尿外科杂志2011，32，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员